Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-015888
Filing Date
2025-04-01
Accepted
2025-04-01 16:06:08
Documents
1
Period of Report
2025-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1743537960.html 4  
1 FORM 4 wk-form4_1743537960.xml 4 3452
  Complete submission text file 0001628280-25-015888.txt   4977
Mailing Address 24 TAMALPAIS AVE MILL VALLEY CA 94941
Business Address
LEDGER STEVEN A (Reporting) CIK: 0001090206 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 25799629

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)